Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk M Nettelbeck

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Anti-Cancer Drugs|September 23, 2003
Virotherapeutics: conditionally replicative adenoviruses for viral oncolysisDirk M Nettelbeck
Journal of Molecular Medicine (Berlin, Germany)|January 25, 2008
Cellular genetic tools to control oncolytic adenoviruses for virotherapy of cancerDirk M Nettelbeck
Scientific American|September 30, 2003
Tumor-busting virusesDirk M Nettelbeck, David T Curiel
Trends in Molecular Medicine|May 29, 2012
Virus chimeras for gene therapy, vaccination, and oncolysis: adenoviruses and beyondJohanna K Kaufmann, Dirk M Nettelbeck
Advanced Drug Delivery Reviews|April 28, 2009
Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysisDominik E Dorer, Dirk M Nettelbeck
Mabs|November 8, 2021
Viro-antibody therapy: engineering oncolytic viruses for genetic delivery of diverse antibody-based biotherapeuticsRoland E Kontermann, Guy Ungerechts, Dirk M Nettelbeck
International Journal of Cancer|August 29, 2007
Combining adenoviral oncolysis with temozolomide improves cell killing of melanoma cellsChristina Quirin, Astrid Mainka, Andrea Hesse, et al.
Journal of Virology|December 29, 2006
Tropism modification of adenovirus vectors by peptide ligand insertion into various positions of the adenovirus serotype 41 short-fiber knob domainAndrea Hesse, Daniela Kosmides, Roland E Kontermann, et al.
Therapeutic Delivery|July 27, 2012
17th Annual Meeting of the German Society for Gene TherapyHildegard Büning, Christopher Baum, Anja Ehrhardt, et al.
Human Gene Therapy|December 23, 2006
Evaluation of twenty human adenoviral types and one infectivity-enhanced adenovirus for the therapy of soft tissue sarcomaDennis Hoffmann, Albert Heim, Dirk M Nettelbeck, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Anti-Cancer Drugs|September 23, 2003
Virotherapeutics: conditionally replicative adenoviruses for viral oncolysisDirk M Nettelbeck
Journal of Molecular Medicine (Berlin, Germany)|January 25, 2008
Cellular genetic tools to control oncolytic adenoviruses for virotherapy of cancerDirk M Nettelbeck
Scientific American|September 30, 2003
Tumor-busting virusesDirk M Nettelbeck, David T Curiel
Trends in Molecular Medicine|May 29, 2012
Virus chimeras for gene therapy, vaccination, and oncolysis: adenoviruses and beyondJohanna K Kaufmann, Dirk M Nettelbeck
Advanced Drug Delivery Reviews|April 28, 2009
Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysisDominik E Dorer, Dirk M Nettelbeck
Mabs|November 8, 2021
Viro-antibody therapy: engineering oncolytic viruses for genetic delivery of diverse antibody-based biotherapeuticsRoland E Kontermann, Guy Ungerechts, Dirk M Nettelbeck
International Journal of Cancer|August 29, 2007
Combining adenoviral oncolysis with temozolomide improves cell killing of melanoma cellsChristina Quirin, Astrid Mainka, Andrea Hesse, et al.
Journal of Virology|December 29, 2006
Tropism modification of adenovirus vectors by peptide ligand insertion into various positions of the adenovirus serotype 41 short-fiber knob domainAndrea Hesse, Daniela Kosmides, Roland E Kontermann, et al.
Therapeutic Delivery|July 27, 2012
17th Annual Meeting of the German Society for Gene TherapyHildegard Büning, Christopher Baum, Anja Ehrhardt, et al.
Human Gene Therapy|December 23, 2006
Evaluation of twenty human adenoviral types and one infectivity-enhanced adenovirus for the therapy of soft tissue sarcomaDennis Hoffmann, Albert Heim, Dirk M Nettelbeck, et al.
Pageof 7